The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients

    • 1Department of Bioinformatics and Computational Biology, Genentech Inc., South San Francisco, California 94080, USA;
    • 2Complete Genomics Inc., Mountain View, California 94043, USA;
    • 3Department of Molecular Biology, Genentech Inc., South San Francisco, California 94080, USA;
    • 4Department of Pathology, Genentech Inc., South San Francisco, California 94080, USA;
    • 5Department of Microbial Pathogenesis, Genentech Inc., South San Francisco, California 94080, USA
    • 6 These authors contributed equally to this work.
    • 7 Corresponding author. E-mail [email protected].
Published January 20, 2012. https://doi.org/10.1101/gr.133926.111
Download PDF Cite Article Permissions Share
cover of Genome Research Vol 36 Issue 5
Current Issue:

Abstract

Hepatitis B virus (HBV) infection is a leading risk factor for hepatocellular carcinoma (HCC). HBV integration into the host genome has been reported, but its scale, impact and contribution to HCC development is not clear. Here, we sequenced the tumor and nontumor genomes (>80× coverage) and transcriptomes of four HCC patients and identified 255 HBV integration sites. Increased sequencing to 240× coverage revealed a proportionally higher number of integration sites. Clonal expansion of HBV-integrated hepatocytes was found specifically in tumor samples. We observe a diverse collection of genomic perturbations near viral integration sites, including direct gene disruption, viral promoter-driven human transcription, viral-human transcript fusion, and DNA copy number alteration. Thus, we report the most comprehensive characterization of HBV integration in hepatocellular carcinoma patients. Such widespread random viral integration will likely increase carcinogenic opportunities in HBV-infected individuals.

Loading
Loading
Loading
Back to top